Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The burden of inflammatory bowel disease in Europe in 2020
New data suggest that incidence and prevalence of inflammatory bowel diseases [IBD] are
still increasing worldwide, and approximately 0.2% of the European population suffer from …
still increasing worldwide, and approximately 0.2% of the European population suffer from …
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase
worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease …
worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease …
Tumor necrosis factor inhibitors for inflammatory bowel disease
Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
[HTML][HTML] Incidence, clinical characteristics and management of inflammatory bowel disease in Spain: large-scale epidemiological study
M Chaparro, A Garre, A Núñez Ortiz… - Journal of clinical …, 2021 - mdpi.com
(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe
the main epidemiological and clinical characteristics at diagnosis and the evolution of the …
the main epidemiological and clinical characteristics at diagnosis and the evolution of the …
Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents
RCA van Linschoten, E Visser… - Alimentary …, 2021 - Wiley Online Library
Background Knowledge of the cost of illness of inflammatory bowel disease (IBD) is
essential for health policy makers worldwide. Aim To assess the cost of illness of IBD from …
essential for health policy makers worldwide. Aim To assess the cost of illness of IBD from …
Epidemiological, clinical, patient-reported and economic burden of inflammatory bowel disease (ulcerative colitis and Crohn's disease) in Spain: a systematic review
M Barreiro-de Acosta, A Molero, E Artime… - Advances in …, 2023 - Springer
Introduction This study describes the epidemiological, clinical, patient-reported and
economic burden of inflammatory bowel disease (IBD), including Crohn's disease (CD) and …
economic burden of inflammatory bowel disease (IBD), including Crohn's disease (CD) and …
Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases–a Danish nationwide cohort study
Background Therapeutic management of inflammatory bowel diseases (IBD) is rapidly
evolving, with an expanding armoury of biological drugs at our disposal. However, real …
evolving, with an expanding armoury of biological drugs at our disposal. However, real …
Delays related to prior authorization in inflammatory bowel disease
BD Constant, EF de Zoeten, MG Stahl… - …, 2022 - publications.aap.org
BACKGROUND Delays in advancing to biologic therapies are associated with adverse
outcomes in inflammatory bowel disease (IBD). Insurer-mandated prior authorizations have …
outcomes in inflammatory bowel disease (IBD). Insurer-mandated prior authorizations have …
Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
L Peyrin-Biroulet, WJ Sandborn… - Therapeutic …, 2021 - journals.sagepub.com
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …
Relevance of monitoring transmural disease activity in patients with Crohn's disease: current status and future perspectives
R Wilkens, KL Novak, C Maaser… - Therapeutic …, 2021 - journals.sagepub.com
Treatment targets of inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn's
disease (CD) have evolved over the last decade. Goals of therapy consisting of symptom …
disease (CD) have evolved over the last decade. Goals of therapy consisting of symptom …